Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

Institut de recherches cliniques de Montréal

$120,000.00

Feasibility and adoption of an early-stage screening program for relatives of individuals with type 1 diabetes in Canada - The FEDERATE-Can study

FY 2025-26

Summary
What if we could detect (and possibly delay) Type 1 Diabetes (T1D) before it even starts? In T1D, the body's immune system mistakenly attacks the insulin-producing cells in the pancreas. Insulin is essential for controlling blood sugar (glycemia). People living with T1D need to take insulin injections daily for life and are at risk of serious health complications over time. For many, the first encounter with T1D is through a sudden and high glycemia or diabetic ketoacidosis (DKA), a life-threatening emergency often requiring a long and stressful hospital stay. This rough start can make glycemia harder to manage later on. We now know that the disease begins long before symptoms or even changes in glycemia. In this early "preclinical" phase, markers of the immune attack can already be detected in the blood. Studies show that early screening can reduce the risk of DKA, help preserve remaining pancreatic function and, with novel treatments, delay the onset of clinical T1D. Early screening could also allow for a gentler, more supported transition into life with T1D. Children, siblings, and parents of people with T1D (known as first-degree relatives) are 15x more likely to develop the disease than the general population. While international guidelines recommend early screening for T1D in first-degree relatives, no screening program exists in Canada. International studies show that people's participation in these programs can vary, which influences its potential health benefits. Therefore, we propose to investigate whether early screening would be feasible and acceptable in Quebec, starting with 1,000 first-degree relatives of people with T1D. We will offer them screening and follow anyone who tests positive for up to 3 years. We will monitor the uptake and collect clinical and biological data (e.g., glycemia) throughout the study. The knowledge gained will help clinicians and policymakers decide how best to introduce early screening and improve care for people at risk.
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
559805
Name
Lebbar Maha
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
DT2 (Health services and population health research) CGRS Doctoral
Projecttitle
Feasibility and adoption of an early-stage screening program for relatives of individuals with type 1 diabetes in Canada - The FEDERATE-Can study
Programtype2
Studentship Programs
Orgnameinp2
Institut de recherches cliniques de Montréal
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Feasability; Screening; Type 1 Diabetes
Abstract
What if we could detect (and possibly delay) Type 1 Diabetes (T1D) before it even starts? In T1D, the body's immune system mistakenly attacks the insulin-producing cells in the pancreas. Insulin is essential for controlling blood sugar (glycemia). People living with T1D need to take insulin injections daily for life and are at risk of serious health complications over time. For many, the first encounter with T1D is through a sudden and high glycemia or diabetic ketoacidosis (DKA), a life-threatening emergency often requiring a long and stressful hospital stay. This rough start can make glycemia harder to manage later on. We now know that the disease begins long before symptoms or even changes in glycemia. In this early "preclinical" phase, markers of the immune attack can already be detected in the blood. Studies show that early screening can reduce the risk of DKA, help preserve remaining pancreatic function and, with novel treatments, delay the onset of clinical T1D. Early screening could also allow for a gentler, more supported transition into life with T1D. Children, siblings, and parents of people with T1D (known as first-degree relatives) are 15x more likely to develop the disease than the general population. While international guidelines recommend early screening for T1D in first-degree relatives, no screening program exists in Canada. International studies show that people's participation in these programs can vary, which influences its potential health benefits. Therefore, we propose to investigate whether early screening would be feasible and acceptable in Quebec, starting with 1,000 first-degree relatives of people with T1D. We will offer them screening and follow anyone who tests positive for up to 3 years. We will monitor the uptake and collect clinical and biological data (e.g., glycemia) throughout the study. The knowledge gained will help clinicians and policymakers decide how best to introduce early screening and improve care for people at risk.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lebbar, Maha
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~